They Just Don't Get...
Health Care: Drugs
Pharmos Corporation (PARS: OTC)
$0.06 0.00 | -1.07%
05/24/12 - 02:26 PM ET
2.08K / 50.80K
Vol / Avg. Vol:0.06 / 0.07
Open / Prev. Close:0.06 - 0.06
Today's Range:0.04 - 0.14
52 Wk Range:34.46%
Performance YTD:TheStreet Rating:
Portfolios with PARS
- Portfolio NameUser Type
- ContributorBarron's Insider Purchases ...
- Userhigh risk micro cap
- UserBP's Under $1 Fund
- Userteegee Portfolio 1
- Userjoecav59 Portfolio 1
- Userdoogan
- UserRon Q's
- Userecilft
- UserAugust Portfolio 1
Latest PARS Headlines from TheStreet
- IBM Flashes Blade Acquisition 09.27.10 | 01:09 pm
- IBM or HP to Buy Radware: Report 09.14.10 | 04:09 pm
- HP Tightens Its Security Via ArcSight Deal 09.13.10 | 01:09 pm
- Friday's Small-Cap Winners & Losers 06.20.07 | 12:06 am
- Tuesday's Small-Cap Winners & Losers 05.02.07 | 09:05 pm
- Exec. Interview: Pharmos Corp.
11.08.06 | 01:11 pm - Pharmos Stumbles Ahead of Crucial Study 11.23.04 | 07:11 am
- Pharmos Journeys to Center of the Mind 11.15.04 | 10:11 am
- Health Stocks in Motion 08.23.04 | 04:08 pm
Press Releases for PARS
- Pharmos Provides Update On Ongoing Clinical Trial Of Levotofisopam For The Treatment Of Gout - PR Newswire 04.05.12 | 04:04 pm
- Pharmos Announces Dosing Of First Patients In Clinical Trial Of Levotofisopam For The Treatment Of Gout - PR Newswire 01.10.12 | 04:01 pm
- Pharmos Corporation Reports Fourth Quarter And Full Year 2009 Results - PR Newswire 02.22.10 | 04:02 pm
Partner Headlines for PARS
